Cara Therapeutics, Inc. (CARA): Price and Financial Metrics
Cara Therapeutics, Inc. (CARA)
Today's Latest Price: $15.37 USD
0.25 (-1.60%)
Updated Jun 5 4:00pm
Add CARA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CARA Stock Summary
- Of note is the ratio of Cara Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 6.21% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for Cara Therapeutics Inc is higher than it is for about just 6.9% of US stocks.
- With a price/sales ratio of 30.48, Cara Therapeutics Inc has a higher such ratio than 95.15% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Cara Therapeutics Inc, a group of peers worth examining would be ANAB, MGNX, VBLT, WVE, and CRBP.
- CARA's SEC filings can be seen here. And to visit Cara Therapeutics Inc's official web site, go to www.caratherapeutics.com.
CARA Daily Price Range
CARA 52-Week Price Range
CARA Stock Price Chart More Charts
CARA Price/Volume Stats
| Current price | $15.37 | 52-week high | $27.55 |
| Prev. close | $15.62 | 52-week low | $8.88 |
| Day low | $15.35 | Volume | 522,444 |
| Day high | $16.15 | Avg. volume | 552,922 |
| 50-day MA | $14.81 | Dividend yield | N/A |
| 200-day MA | $17.51 | Market Cap | 719.25M |
Cara Therapeutics, Inc. (CARA) Company Bio
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. The company was founded in 2004 and is based in Shelton, Connecticut.
Loading social stream, please wait...